Diagnostic criteria for atopic bronchial asthma.
Reading Document
Medical Text Search
atopic bronchial asthma diagnostic criteria
Medical Text Search
asthma diagnosis spirometry reversibility airflow obstruction
GradeResponse
GradeResponse
The retrieved results are limited in scope. I'll provide a comprehensive answer drawing from established guidelines (GINA) and clinical knowledge, supplemented by the retrieved content.
Diagnostic Criteria for Atopic Bronchial Asthma
1. What is Atopic (Allergic) Asthma?
Atopic bronchial asthma is the most common asthma phenotype. It is characterized by IgE-mediated airway inflammation triggered by allergen sensitization. It typically begins in childhood, associates with a personal or family history of atopy (allergic rhinitis, eczema, food allergy), and shows eosinophilic airway inflammation.
2. Diagnostic Criteria
Diagnosis requires both evidence of variable airflow limitation and clinical/atopic features.
A. Clinical Criteria (History & Symptoms)
Classic symptom triad:
| Symptom | Characteristic Pattern |
|---|---|
| Wheeze | Recurrent, often bilateral, expiratory |
| Dyspnea | Episodic, variable |
| Cough | Dry, nocturnal/early morning predominance |
| Chest tightness | Accompanying wheezing episodes |
Key clinical features supporting atopic asthma:
- Symptoms triggered by allergens (dust mites, pollen, animal dander, mold, cockroach)
- Symptoms also triggered by exercise, cold air, viral infections, irritants
- Nocturnal and early morning worsening
- Symptoms vary over time and in intensity
- Symptoms worsen seasonally (correlating with allergen season)
- Personal history of atopic disease: allergic rhinitis, allergic conjunctivitis, atopic dermatitis (eczema), food allergy
- Family history of asthma or atopy
- Onset typically in childhood or early adulthood
B. Objective Evidence of Variable Airflow Limitation (Spirometry)
At least one of the following must be demonstrated:
| Test | Positive Criterion |
|---|---|
| Post-bronchodilator reversibility | FEV₁ increase ≥12% AND ≥200 mL after SABA (salbutamol 400 mcg) |
| Excessive variability in PEF | Diurnal PEF variability >10% (adults), >13% (children) over ≥2 weeks |
| Bronchoprovocation test | Significant fall in FEV₁ (≥20%) with methacholine, histamine, or mannitol (PC₂₀ ≤8 mg/mL methacholine) |
| Exercise challenge | FEV₁ fall ≥10% AND ≥200 mL after standardized exercise |
| Significant FEV₁ increase after treatment | FEV₁ increase ≥12% AND ≥200 mL after 4 weeks of anti-inflammatory therapy |
Spirometric pattern: Obstructive pattern — reduced FEV₁/FVC ratio (<0.70 or below LLN) that reverses with bronchodilator.
C. Evidence of Atopic Sensitization (for Atopic Asthma Specifically)
| Investigation | Finding |
|---|---|
| Skin prick test (SPT) | Positive wheal ≥3 mm to one or more aeroallergens |
| Serum specific IgE | Elevated specific IgE to relevant allergens (RAST/ImmunoCAP) |
| Total serum IgE | Often elevated (though nonspecific) |
| Blood eosinophils | Elevated (≥150–300 cells/μL supports T2-high/eosinophilic phenotype) |
| FeNO (Fractional exhaled NO) | ≥25 ppb at 50 mL/s flow rate suggests eosinophilic/atopic airway inflammation |
D. Supporting Investigations
| Test | Purpose |
|---|---|
| Full pulmonary function tests | Rule out restrictive disease; assess air trapping (elevated RV, TLC) |
| Chest X-ray | Rule out alternative diagnoses (hyperinflation in acute attack, normal between attacks) |
| Blood CBC | Eosinophilia (>300–500/μL suggestive) |
| Nasal smear / rhinoscopy | Confirm allergic rhinitis (pale/blue turbinates, eosinophils) |
| Patch testing / food diary | If food allergen trigger is suspected |
3. GINA Diagnostic Algorithm (Summary)
Episodic respiratory symptoms (wheeze, dyspnea, cough, chest tightness)
↓
Spirometry with bronchodilator test
↓
FEV₁/FVC reduced + reversibility ≥12% & ≥200 mL?
YES → Asthma confirmed
NO → Bronchoprovocation test OR serial PEF monitoring
↓
Add: Skin prick test / specific IgE
Positive → Atopic (allergic) asthma phenotype
4. Differentiating Atopic Asthma from Other Asthma Phenotypes
| Feature | Atopic Asthma | Non-atopic Asthma | COPD |
|---|---|---|---|
| Onset | Childhood/young adult | Adult onset | >40 yrs, smoker |
| Atopy | Present | Absent | May be present |
| Eosinophils | High | Variable | Neutrophilic |
| Reversibility | Complete | Partial | Partial/absent |
| FeNO | Elevated | Normal | Normal/low |
| Allergen triggers | Yes | No | Rare |
5. Diagnostic Pitfalls
- Normal spirometry does not exclude asthma — patients may have normal FEV₁ between episodes; serial PEF or bronchoprovocation is then needed.
- Positive atopy does not equal asthma — ~40% of the general population is atopic; sensitization must be clinically relevant.
- FeNO is not diagnostic alone — it supports atopic/eosinophilic phenotype but must be interpreted with clinical context.
- Over-reliance on symptoms — variable symptoms alone are insufficient; objective airflow limitation must be demonstrated per GINA 2023 guidelines.
Key References: GINA (Global Initiative for Asthma) Report 2023; Asthma Management Guidelines (p. 53); Harrison's Principles of Internal Medicine, 21st ed.
This is a shared conversation. Sign in to Orris to start your own chat.